Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial

INTRODUCTION: Biannual mass azithromycin distribution to children aged 1–59 months has been shown to reduce all-cause mortality. Children under 28 days of age were not treated in studies evaluating mass azithromycin distribution for child mortality due to concerns related to infantile hypertrophic p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sie, Ali, Bountogo, Mamadou, Nebie, Eric, Ouattara, Mamadou, Coulibaly, Boubacar, Bagagnan, Cheik, Zabre, Pascal, Lebas, Elodie, Brogdon, Jessica, Godwin, William W, Lin, Ying, Porco, Travis, Doan, Thuy, Lietman, Thomas M, Oldenburg, Catherine E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731835/
https://www.ncbi.nlm.nih.gov/pubmed/31488494
http://dx.doi.org/10.1136/bmjopen-2019-031162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731835/
https://www.ncbi.nlm.nih.gov/pubmed/31488494
http://dx.doi.org/10.1136/bmjopen-2019-031162

Ejemplares similares